Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of UVA1-irradiation in the Treatment of Early Skin Fibrosis in Patients Suffering From Systemic Sclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* systemic sclerosis ACR criteria~* skin fibrosis at least involving the distal third of the lower arm~Exclusion Criteria:~* photosensitizing drugs~* recent UV therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- A UVA1 B no UVA1 (Type: OTHER): half body irradiation with random allocation right and left; after three months of treatment treatment of both sides
- A UVA1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).